Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Medulloblastoma Recurrent: early-phase trial registry
3 of 4 indexed Medulloblastoma Recurrent trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Medulloblastoma Recurrent: 4 US clinical trials tracked, 3 recruiting.
Medulloblastoma Recurrent is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Mohammad H. Abu Arja, running 1 of these trials.
Enrollment posture brief
Registry condition medulloblastoma-recurrent
OPEN 3 | RECR 75% | LATE 0 | EARLY 2 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Medulloblastoma Recurrent lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Medulloblastoma Recurrent on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Medulloblastoma Recurrent is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
Mohammad H. Abu Arja
NCT07242963
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Medical University of Vienna
NCT01356290
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
University of California, San Francisco
NCT05057702
Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT
Sabine Mueller, MD, PhD
NCT02962167
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Medulloblastoma Recurrent records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Medulloblastoma Recurrent trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Medulloblastoma Recurrent page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Medulloblastoma Recurrent trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Mohammad H. Abu Arja sponsors the most Medulloblastoma Recurrent trials on record, review their full trial history before evaluating a specific study. See Mohammad H. Abu Arja's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Medulloblastoma Recurrent condition card totals 4 registered trials; most-linked intervention Modified Measles Virus Lumbar Puncture; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.